Takeover

Acquirers

TapImmune Inc.

Targets
1
Filings
2
Median premium
100%
First filing
Jul 13, 2018
Latest filing
Sep 14, 2018

Targets

CompanyScore before dealScore nowFilingsLatest
MRKRMarker Therapeutics, Inc.—0 / 132Sep 14, 2018

Deal filings

FiledCompanyFormPricePremium
Sep 14, 2018MRKRMarker Therapeutics, Inc.DEFM14A$4.00100%
Jul 13, 2018MRKRMarker Therapeutics, Inc.PREM14A$42.1542.1545285%